HP and cancer: By performing our analysis at the zebrafish larval stage, we could evaluate the anticancer therapeutic activity of HP-NAP net of any adaptive immune response, and this not only allowed us to finely dissect the effects of the protein on the innate immunity components, but also highlighted the potential and feasibility of a HP-NAP-based cancer therapy, in case of a compromised activity of lymphocytes.